We look at the research catching experts’ attention in this rapidly evolving field.

New approach paves the way to making dendritic cell vaccines more effective.

A newly discovered stretch of human DNA provides a specific example of how this could happen.

New discovery changes our understanding of how viruses are transmitted.

Switching enzymes from Cas9 to Cas12a would mean safer and more effective gene editing.

Researchers say the common supplement’s benefits are unproven, while risks are clear. 

New findings suggest that drugs already in development for a small percentage of patients could treat most people with the disease.

A recent study found CRISPR-Cas9 gene editing may be less precise than previously thought.

The drug reactivates nerve pathways in partially severed spinal cords.

Working copies of the gene were delivered directly into the brains of mouse fetuses before they were born.

But the risk from estrogen therapy is still small, researchers say.

Scientists say human trials will follow in five to ten years.

PI3K inhibiting drugs have shown little success. Now researchers may have figured out why.

In a first, rhinoceros embryos have been developed in vitro to be ready for implantation.

People with a family history of multiple sclerosis may want to avoid solvents like turpentine and nail polish remover, say researchers.

Herpesvirus genes found in patients’ brains provide unprecedented evidence for a connection, but the viruses’ exact role remains unclear.

The process uses no toxic chemicals and promises to produces DNA strands 10 times longer than today’s methods.

Researchers have found a way to predict who’s most likely to get the flu.

Drugs like LSD help neurons reach out to each other, a promising path for pharmaceutical development.

Sour tastes could be used to either promote or inhibit risk-taking behavior.